Web Trading Login
Report Dashboard
Home
Products & Services
Trading Platforms
Merchant Banking
RTA Services
RTA Services
Investor Portal
ISIN Enquiry
About Us
Partner With Us
Contact Us
LOGIN
Web Trading Login
Report Dashboard
OPEN AN ACCOUNT
Home
Products & Services
Equity
Fixed Income
Derivatives
Commodities
Mutual Fund
Insurance
Trading Platforms
Merchant Banking
RTA Services
RTA Services
Investor Portal
ISIN Enquiry
About Us
Partner With Us
Contact Us
A+
|
A
|
A-
|
Skip to Main Content
Indian Indices
Sensex
76,765.92
-69.86
( -0.09%)
Global Indices
Nasdaq
52,223.83
255.58
(0.49%)
Dow Jones
7,434.43
1.45
(0.02%)
Hang Seng
62,158.55
-2,772.64
(-4.27%)
Nikkei 225
10,879.18
97.43
(0.90%)
Forex
USD-INR
96.67
0.19
(0.20%)
EUR-INR
110.18
0.12
(0.10%)
GBP-INR
129.04
-0.01
(0.00%)
JPY-INR
0.59
0.00
(-0.04%)
Equities
Derivative
Commodity
Mutual Fund
IPO
Insurance
Daily Market Tracker
Gainers & Losers
Value/Volume Toppers
52 Week High/Low
New High Low
Advances & Declines
Live Indices
Block Deals
Bulk Deals
Only Buyers / Sellers
Unusual Volume
Out / Under Performers
Index Movers
Exchange Holidays
Historical Returns
Index Constituents
Sector Watch
News
Pre-Session
Mid-Session
End-Session
Market Beat
Hot Pursuit
Economy News
Corporate News
Foreign Markets
Other Markets
Stock Alert
Corporate Results
Quick Peek
Mutual Fund News
Derivative News
Analyst Poll
Political News
IPO News
Corporate Actions
Bse Announcements
Book Closure
Board Meetings
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change Of Name
Split Of Face Value
Corporate Information
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit and Loss
Quarterly Results
Financial Ratios
Share Holding Pattern
Score Board
Director's Report
MF Holdings
Name Change
Monthly Highlow
Company News
Peer Comparison
Technical Chart
Interactive Chart
Other Markets
ADR Prices
FII Investments
MF Investments
World Indices
Forex
Indian Indices
Equity
Derivative
Commodity
Mutual Fund
IPO
Insurance
Daily Market Tracker
News
Corporate Action
Corporate Information
Other Markets
--select--
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit and Loss
Quarterly Results
Financial Ratios
Share Holding Pattern
Director's Report
MF Holdings
Name Change
Monthly Highlow
Company News
Peer Comparison
Score Board
Technical Chart
Interactive Chart
YOU ARE HERE :
HOME
Markets
Equity
Company Snapshot
EQUITY - MARKET SCREENER
Daily Market Tracker
News
Corporate Action
Corporate Information
Other Markets
--select--
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit and Loss
Quarterly Results
Financial Ratios
Share Holding Pattern
Director's Report
MF Holdings
Name Change
Monthly Highlow
Company News
Peer Comparison
Score Board
Technical Chart
Interactive Chart
Glenmark Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
532296
INE935A01035
855.7849313
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GLENMARK
38.7
61927.56
EPS(TTM)
Face Value(
)
Div & Yield %
56.7
1
0.11
BSE
As on:
Jul 28, 2026 12:00 AM
Last Price(
)
Net Change (%)
Volume (Nos)
P / E
2,184.90
-9.55
4761
38.70
Stock Price Details
Open Price(
)
2,194.65
Best Buy (
)
0
Best Sell (
)
0
Buy Quantity (Nos)
0
Sell Quantity (Nos)
0
Today's High (
)
2,207.95
Today's Low (
)
2,179.40
52-Week High (
)
2471.05
152-Week Low (
)
1794
CHART
|
|
|
|
Market Statistics
Div & Yield %
0.11
Eps
56.7
Book Value
855.7849313
Market Cap (
.Cr)
61,927.56
Face Value
1
Market Lot
1
AGM Date
Sep
Book Closure Date
Sep
ISIN No.
INE935A01035
News
Glenmark receives USFDA approval for expanded use of RYALTRIS® for pediatric patients
Glenmark Pharmaceuticals announces board meeting date
Glenmark Pharmaceuticals Ltd soars 0.08%, up for fifth straight session
Glenmark USA launches Olanzapine for Injection
Glenmark Pharma gains as US arm launches generic Olanzapine injection
Glenmark Pharmaceuticals Ltd stays supported
Glenmark advances multi-country Phase 3 clinical trial for Trastuzumab rezetecan
Glenmark Pharmaceuticals launches Methylene Blue Injection USP in U.S.
Glenmark Pharma arm launches generic Methylene Blue Injection in US market
Glenmark launches Winlevi® in key European markets
More
Corporate Details
Incoporation Year : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail :
complianceofficer@glenmarkpharma.com
URL :
http://www.glenmarkpharma.com
Exchange Information
Bombay Stock Exchange
National Stock Exchange
Other Listed Exchanges
BSE 500
BSE HC
BSE Midcap
BSE Shariah 50
MIDCAP 200
CNX 500
CNX Midcap
CNX Pharma
CNX 200
BSE
Kolkata
Chennai
Ahmedabad
Delhi
Kochi
×
Filing complaints on SCORES – Easy & quick
a.
Register on SCORES portal
b.
Mandatory details for filing complaints on SCORES :
i. Name, PAN, Address, Mobile Number, Email ID
c.
Benefits :
i. Effective communication
ii. Speedy redressal of the grievances
SEBI Circular on "Master Circular on the redressal of investor grievances through the SEBI Complaints Redress System (SCORES) platform". Please refer below path for information.
https://www.sebi.gov.in/legal/master-circulars/nov-2022/master-circular-on-the-redressal-of-investor-grievances-through-the-sebi-complaints-redress-system-scores-platform_64742.html#
Click here
to visit SEBI Scores